Spherical Nucleic Acids Deliver a New Package for Oliognucleotide Therapeutics
SNAs Are a Hopeful First Step in Boosting the Utility of Oligonucleotides to Treat a Variety of Human Diseases
Downstream Issues Still Beset Production
To Protect the Bottom Line, Biomanufacturers Invest in Downstream Purification Technology
GEN Roundup: No Detail Is Too Small in Bioprocess Scaleup
A Change in Scale Can Change Everything
Amid Election Clamor, Research Issues Surface
Sounds of Science Podcast
For full access to this article login to GEN Select now.
Optimizing Utilization of Biomarkers
Better Dialogue from Discovery to Clinic Could Be Key to Improving Process
- Biomarker discovery has exploded in the last decade, yet researchers often struggle to validate their biomarkers for widespread clinical use. Several recent meetings including CHI’s “Molecular Medicine Tri-Conference” and “Biomarker World Congress” as well as SMi’s “Biomarker Summit” highlighted current challenges, offered new insights, and presented cutting-edge technological advances. ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.